会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods for treatment of aneurysms
    • 治疗动脉瘤的方法
    • US06719778B1
    • 2004-04-13
    • US09534786
    • 2000-03-24
    • Robert A. Van TasselMichael Kasinkas
    • Robert A. Van TasselMichael Kasinkas
    • A61N501
    • A61N5/062A61N5/0601
    • Fibrosis, in at least one layer of a vessel wall, can be used to strengthen a vessel wall. Fibrosis can be induced by irradiating a vessel wall with an energy source, or by inducing injury to the vessel wall. In addition to an energy source, photoactivatable agents can also be used such that the energy activates the photoactivatable agent to cause a thickening of the vessel wall. For example, ultra-violet radiation can be used alone or in conjunction with a photoactivatable agent, such as a psoralen compound, to increase the adventitial volume of a blood vessel. Upon exposure to radiation, preferably ultra-violet A radiation, the photoactivatable agent becomes activated and causes compositional and/or structural changes in the adventitia. The invention provides a method of treating aneurysms by thickening the adventitial layer of the vessel wall at the site of the aneurysm.
    • 在血管壁的至少一层中的纤维化可用于加强血管壁。 可以通过用能量源照射血管壁或通过诱导血管壁的损伤来诱导纤维化。 除了能量源之外,还可以使用光活化剂,使得能量激活可光活化剂以引起血管壁的增厚。 例如,紫外辐射可以单独使用或与可光活化剂如补骨脂素化合物联合使用,以增加血管的外膜体积。 在暴露于辐射,优选紫外线A辐射时,可光活化剂变得活化并引起外膜中的组成和/或结构变化。 本发明提供了通过在动脉瘤部位增厚血管壁的外膜层来治疗动脉瘤的方法。
    • 2. 发明授权
    • Treatment of in-stent restenosis using cytotoxic radiation
    • 使用细胞毒性辐射治疗支架内再狭窄
    • US06520957B1
    • 2003-02-18
    • US09712709
    • 2000-11-14
    • Michael KasinkasRobert A. Van Tassel
    • Michael KasinkasRobert A. Van Tassel
    • A61B1818
    • A61N5/0601A61B17/22A61B18/24A61B2017/22002A61B2017/22059A61B2017/22064A61B2017/22087A61B2018/2261A61N2005/0661
    • Methods and systems are disclosed for treating in-stent restenosis using radiation having a wavelength sufficient to kill or promote cellular death (e.g., through programmed cell death), or otherwise remove smooth muscle cells which have proliferated, or which might otherwise proliferate, in the proximity of (i.e., within, around or adjacent to) a stent within a body lumen, causing (or potentially causing) at least partial blockage of the lumen. Devices are disclosed for providing such therapeutic radiation at the stent with or without concurrent mechanical (e.g. balloon dilation) angioplasty. Treatment methods are also disclosed which include irradiating smooth muscle cells in the region of the stenosis with non-ablative, cytotoxic radiation, such as UV radiation. A cytotoxic, photoactivatable chromophore may also be delivered to the treatment site prior to irradiation. The methods and systems can be used prophylactically or to treat in-stent restenosis after blockage has occurred without further damage to surrounding tissue.
    • 公开了用于使用具有足以杀死或促进细胞死亡(例如通过程序性细胞死亡)的波长的辐射治疗支架内再狭窄的方法和系统,或以其它方式去除已经增殖或可能在其中增殖的平滑肌细胞 支架在体腔内(即,在其内,周围或邻近)附近,引起(或潜在地引起)至少部分阻塞内腔。 公开了用于在具有或不具有并行机械(例如球囊扩张)血管成形术的情况下在支架处提供这种治疗放射线的装置。 还公开了治疗方法,其包括在非消融性,细胞毒性辐射(例如UV辐射)下在狭窄区域照射平滑肌细胞。 在照射之前,细胞毒性的可光活化的发色团也可以被递送到治疗部位。 该方法和系统可以预防性地使用或在阻塞发生后治疗支架内再狭窄,而没有对周围组织的进一步损伤。
    • 3. 发明授权
    • Treatment of in-stent restenosis using cytotoxic radiation
    • 使用细胞毒性辐射治疗支架内再狭窄
    • US06200307B1
    • 2001-03-13
    • US09083358
    • 1998-05-22
    • Michael KasinkasRobert A. Van Tassel
    • Michael KasinkasRobert A. Van Tassel
    • A61B1818
    • A61N5/0601A61B17/22A61B18/24A61B2017/22002A61B2017/22059A61B2017/22064A61B2017/22087A61B2018/2261A61N2005/0661
    • A method for treating in-stent restenosis using radiation having a wavelength sufficient to kill or promote cellular death (e.g., through programmed cell death), or otherwise remove smooth muscle cells which have proliferated, or which might otherwise proliferate, in the proximity of (i.e., within, around or adjacent to) a stent within a body lumen, causing (or potentially causing) at least partial blockage of the lumen. The treatment method includes irradiating smooth muscle cells in the region of the stenosis with non-ablative, cytotoxic radiation, such as UV radiation. A cytotoxic, photoactivatable chromophore may also be delivered to the treatment site prior to irradiation. The method can be used prophylactically or to treat in-stent restenosis after blockage has occurred without further damage to surrounding tissue.
    • 使用具有足以杀死或促进细胞死亡(例如通过程序性细胞死亡)的波长的辐射来治疗支架内再狭窄的方法,或以其它方式去除已经增殖或可能增殖的平滑肌细胞,所述平滑肌细胞在 即,在体腔内的支架内,围绕或邻近)导致(或潜在地引起)至少部分阻塞内腔。 治疗方法包括在非消融性细胞毒性辐射(例如紫外线辐射)下在狭窄区域照射平滑肌细胞。 在照射之前,细胞毒性的可光活化的发色团也可以被递送到治疗部位。 该方法可以预防性地使用或在阻塞发生后治疗支架内再狭窄,而不会对周围组织造成进一步的损害。
    • 4. 发明授权
    • Methods for treatment of aneurysms
    • 治疗动脉瘤的方法
    • US08021404B1
    • 2011-09-20
    • US10798786
    • 2004-03-10
    • Robert A. Van TasselMichael Kasinkas
    • Robert A. Van TasselMichael Kasinkas
    • A61N5/01
    • A61N5/062A61N5/0601
    • Fibrosis, in at least one layer of a vessel wall, can be used to strengthen a vessel wall. Fibrosis can be induced by irradiating a vessel wall with an energy source, or by inducing injury to the vessel wall. In addition to an energy source, photoactivatable agents can also be used such that the energy activates the photoactivatable agent to cause a thickening of the vessel wall. For example, ultra-violet radiation can be used alone or in conjunction with a photoactivatable agent, such as a psoralen compound, to increase the adventitial volume of a blood vessel. Upon exposure to radiation, preferably ultra-violet A radiation, the photoactivatable agent becomes activated and causes compositional and/or structural changes in the adventitia. The invention provides a method of treating aneurysms by thickening the adventitial layer of the vessel wall at the site of the aneurysm.
    • 在血管壁的至少一层中的纤维化可用于加强血管壁。 可以通过用能量源照射血管壁或通过诱导血管壁的损伤来诱导纤维化。 除了能量源之外,还可以使用光活化剂,使得能量激活可光活化剂以引起血管壁的增厚。 例如,紫外辐射可以单独使用或与可光活化剂如补骨脂素化合物联合使用,以增加血管的外膜体积。 在暴露于辐射,优选紫外线A辐射时,可光活化剂变得活化并引起外膜中的组成和/或结构变化。 本发明提供了通过在动脉瘤部位增厚血管壁的外膜层来治疗动脉瘤的方法。
    • 5. 发明授权
    • Cardiac stimulation apparatus and method for the control of hypertension
    • 心脏刺激装置及控制高血压的方法
    • US08428729B2
    • 2013-04-23
    • US13281742
    • 2011-10-26
    • Robert S. SchwartzRobert A. Van Tassel
    • Robert S. SchwartzRobert A. Van Tassel
    • A61N1/365
    • A61N1/36514A61N1/3627A61N1/36564
    • A method that electrically stimulates a heart muscle to alter the ejection profile of the heart, to control the mechanical function of the heart and reduce the observed blood pressure of the patient. The therapy may be invoked by an implantable blood pressure sensor associated with a pacemaker like device. In some cases, where a measured pretreatment blood pressure exceeds a treatment threshold, a patient's heart may be stimulated with an electrical stimulus timed relative to the patient's cardiac ejection cycle. This is done to cause dyssynchrony between at least two cardiac chambers or within a cardiac chamber, which alters the patient's cardiac ejection profile from a pretreatment cardiac ejection profile. This has the effect of reducing the patient's blood pressure from the measured pretreatment blood pressure.
    • 一种电刺激心肌以改变心脏的射血分布,控制心脏的机械功能并降低观察到的患者血压的方法。 该治疗可以由与起搏器相似的装置相关联的可植入血压传感器来调用。 在一些情况下,在测量的预处理血压超过治疗阈值的情况下,可以以相对于患者的心脏射血周期计时的电刺激来刺激患者的心脏。 这是为了在至少两个心室之间或心室内引起不同步,其改变患者的心脏射血分布从预处理的心脏射血分布。 这具有从测量的预处理血压降低患者的血压的效果。
    • 6. 发明申请
    • Cardiac Stimulation Apparatus And Method For The Control Of Hypertension
    • 心脏刺激装置及控制高血压的方法
    • US20120041502A1
    • 2012-02-16
    • US13281742
    • 2011-10-26
    • Robert S. SchwartzRobert A. Van Tassel
    • Robert S. SchwartzRobert A. Van Tassel
    • A61N1/362
    • A61N1/36514A61N1/3627A61N1/36564
    • A method that electrically stimulates a heart muscle to alter the ejection profile of the heart, to control the mechanical function of the heart and reduce the observed blood pressure of the patient. The therapy may be invoked by an implantable blood pressure sensor associated with a pacemaker like device. In some cases, where a measured pretreatment blood pressure exceeds a treatment threshold, a patient's heart may be stimulated with an electrical stimulus timed relative to the patient's cardiac ejection cycle. This is done to cause dyssynchrony between at least two cardiac chambers or within a cardiac chamber, which alters the patient's cardiac ejection profile from a pretreatment cardiac ejection profile. This has the effect of reducing the patient's blood pressure from the measured pretreatment blood pressure.
    • 一种电刺激心肌以改变心脏的射血分布,控制心脏的机械功能并降低观察到的患者血压的方法。 该治疗可以由与起搏器相似的装置相关联的可植入血压传感器来调用。 在一些情况下,在测量的预处理血压超过治疗阈值的情况下,可以以相对于患者的心脏射血周期计时的电刺激来刺激患者的心脏。 这是为了在至少两个心室之间或在心室内引起不同步,其改变患者的心脏射血分布从预处理的心脏射血分布。 这具有从测量的预处理血压降低患者的血压的效果。
    • 10. 发明申请
    • Implantable Device For Promoting Repair Of A Body Lumen
    • 用于促进身体内腔修复的植入式装置
    • US20090210050A1
    • 2009-08-20
    • US12429803
    • 2009-04-24
    • Robert A. Van TasselDavid R. Holmes, JR.Robert S. Schwartz
    • Robert A. Van TasselDavid R. Holmes, JR.Robert S. Schwartz
    • A61F2/06
    • A61F2/82A61B5/0031A61B5/028A61B5/6862A61B5/6876A61F2/0077A61F2/91A61L31/14
    • An implantable stent having surface features adapted to promote an organized growth pattern of infiltrating cells when implanted in a tubular organ is provided. The surface features comprise depressions, pores, projections, pleats, channels or grooves in the stent body and are designed to increase turbulence or stagnation in the flow of a liquid, such as blood through the stent, and/or to promote the growth of infiltrating cells in an organized pattern. Alternatively, the invention stent can be populated with living cells prior to implant and can be heatable from an external source of energy, thereby inducing production of therapeutic bioactive agents from ingrowing cells. The invention also provides an implantable heatable stent for transcutaneously monitoring the flow of fluid through a lumen into which the stent is implanted by measuring the rate at which the heated stent cools in response to blood flow when the source of heat is removed.
    • 提供了一种植入式支架,其具有适于在植入管状器官时促进浸润细胞的有组织生长模式的表面特征。 表面特征包括支架主体中的凹陷,孔,突起,褶皱,通道或凹槽,并且被设计成增加液体如血液通过支架的流动中的湍流或停滞,和/或促进渗透的生长 细胞以有组织的模式。 或者,本发明支架可以在植入之前填充活细胞,并且可以从外部能量源加热,从而从向内生长细胞诱导治疗性生物活性剂的产生。 本发明还提供了一种可植入的可加热支架,用于通过测量当热源移除时响应于血液流动而被加热的支架冷却的速率,通过测量支架植入其中的内腔来经皮监测流体的流动。